Skip to main content
. 2021 Sep 28;12(20):2075–2088. doi: 10.18632/oncotarget.28060

Figure 1.

Figure 1

Freedom from progression in 28 patients with intrahepatic cholangiocarcinoma treated with radioembolization, categorized by in-field (A), out-of-field (B), and overall progression (C).